PWS
MRNA icon

Paragon Wealth Strategies’s Moderna MRNA Stock Holding History

Paragon Wealth Strategies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,000
Closed -$243K – 39
2023
Q2 		$243K Sell
2,000
-77
-4% -$10.3K 0.08% 32
2023
Q1 		$319K Buy
2,077
+77
+4% +$12.7K 0.19% 30
2022
Q4 		$359K Hold
2,000
– – 0.43% 18
2022
Q3 		$236K Hold
2,000
– – 0.23% 16
2022
Q2 		$286K Hold
2,000
– – 0.32% 20
2022
Q1 		$345K Hold
2,000
– – 0.09% 40
2021
Q4 		$508K Hold
2,000
– – 0.12% 36
2021
Q3 		$770K Hold
2,000
– – 0.21% 29
2021
Q2 		$470K Hold
2,000
– – 0.13% 33
2021
Q1 		$262K Buy
+2,000
New +$290K 0.08% 37

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Paragon Wealth Strategies's MRNA Position: Q3 2023 in Review

Paragon Wealth Strategies sold out of Moderna (MRNA) in Q3 2023, closing a stake of 2,000 shares — an estimated $243K sold.

Paragon Wealth Strategies first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $770K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Paragon Wealth Strategies reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Paragon Wealth Strategies sold 2,000 Moderna shares in Q3 2023, an estimated $243K.
  • Paragon Wealth Strategies first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Paragon Wealth Strategies's Moderna position peaked at $770K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Paragon Wealth Strategies's 13F filing for Q3 2023, filed 16 Oct 2023.